1. Anti-Müllerian hormone as an ovarian reserve marker in young cancer women who undergo ovarian tissue cryopreservation
- Author
-
Maria Macciocca, Stefano Venturoli, Daniela Terribile, Rossella Vicenti, Raffaella Fabbri, Maria Letizia Bacchi Reggiani, Cristina Melotti, Gianandrea Pasquinelli, Fabbri R, Macciocca M, Melotti C, Pasquinelli G, Vicenti R, Bacchi Reggiani ML, Terribile D, and Venturoli S.
- Subjects
Adult ,Anti-Mullerian Hormone ,endocrine system ,Cancer Research ,Adolescent ,endocrine system diseases ,Early follicular phase ,media_common.quotation_subject ,Andrology ,Young Adult ,Ovarian Follicle ,Neoplasms ,medicine ,Humans ,Ovarian tissue cryopreservation ,Child ,Ovarian Reserve ,Ovarian reserve ,Menstrual Cycle ,Menstrual cycle ,media_common ,Cryopreservation ,ovarian tissue cryopreservation ,biology ,business.industry ,Ovary ,Age Factors ,Cancer ,Anti-Müllerian hormone ,General Medicine ,medicine.disease ,female genital diseases and pregnancy complications ,anti-Müllerian hormone ,primordial follicles ,Oncology ,biology.protein ,Female ,Folliculogenesis ,business ,hormones, hormone substitutes, and hormone antagonists ,Biomarkers ,Gonadal Hormones ,Hormone - Abstract
ABSTRACT: Aim: To evaluate if anti-Müllerian hormone (AMH) is a reliable marker of ovarian reserve in young women undergoing ovarian tissue cryopreservation. Patients & methods: Relationships of serum AMH levels with primordial follicle density, age and reproductive hormones were investigated using the Pearson or Spearman correlation coefficient in 86 women with cancer (12–38 years) undergoing ovarian tissue cryopreservation. AMH variations through the menstrual cycle were assessed by the Kruskal–Wallis test. p
- Published
- 2014
- Full Text
- View/download PDF